|Bid||237.81 x 1000|
|Ask||238.06 x 800|
|Day's Range||234.48 - 239.33|
|52 Week Range||158.38 - 243.30|
|Beta (5Y Monthly)||0.62|
|PE Ratio (TTM)||16.90|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for UTHR
These are the healthcare stocks with the best value, fastest growth, and most momentum for July 2022.
The CHMP recommends approval of Novartis' (NVS) Scemblix for treating adult patients with chronic myeloid leukemia. EU also approves label expansion of Cosentyx.
Sanderson Farms, United Therapeutics, AMN Healthcare are part of zacks Screen of the week article.